John Bomalaski
Corporate Officer/Principal chez POLARIS GROUP
Profil
John Bomalaski is currently the Director & Executive VP-Medical Affairs at Polaris Pharmaceuticals, Inc., the Director at DesigneRx Europe Ltd., the Director at DRX USA, the Director at Polaris Group Korea Ltd., and the Chief Medical Officer & VP-Medical Affairs at EnzymeRx LLC since 2009.
He was also the Deputy General Manager at Polaris Group starting in 2006.
Previously, he worked as a Faculty Member at the University of Pennsylvania and as a Principal at Northwestern University.
Dr. Bomalaski holds a doctorate degree from St. Louis University.
Postes actifs de John Bomalaski
| Sociétés | Poste | Début |
|---|---|---|
| POLARIS GROUP | Corporate Officer/Principal | 01/01/2007 |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Directeur Technique/Scientifique/R&D | - |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 18/12/2009 |
| DRX USA | Directeur/Membre du Conseil | - |
| DesigneRx Europe Ltd. | Directeur/Membre du Conseil | - |
| Polaris Group Korea Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de John Bomalaski
| Sociétés | Poste | Fin |
|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
Formation de John Bomalaski
| St. Louis University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Entreprise privées | 5 |
|---|---|
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DesigneRx Europe Ltd. | |
| DRX USA | |
| Polaris Group Korea Ltd. |
